Nippon India Pharma Fund - Growth Plan - Growth Option

Equity Create Wealth
Sectoral Fund - Pharma & Health Care
Category Rank
Rating
Fund
Time to Invest
NAV
Rs.484.0594 (09/05/2025)
L 52Wk H
419.77
 
530.57

Asset Allocation for Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

Top 10 Holdings of Nippon India Pharma Fund - Growth Plan - Growth Option

60.32 % of total assets
Sun Pharmaceutical Industries Limited(13.88%)
Divi's Laboratories Limited(9.57%)
Lupin Limited(6.30%)
Cipla Limited(6.01%)
Apollo Hospitals Enterprise Limited(5.48%)
Dr. Reddy's Laboratories Limited(5.25%)
GlaxoSmithKline Pharmaceuticals Limited(3.63%)
MedPlus Health Services Limited(3.54%)
Vijaya Diagnostic Centre Limited(3.43%)
Abbott India Limited(3.23%)

Detailed Portfolio of Nippon India Pharma Fund - Growth Plan - Growth Option

Portfolio Date -30 Apr 2025
Equity Holdings -37
Other Holdings -3
  • Equity Holdings

  • Debt Holdings

  • Other Holdings

Holdings % Weight Value Sahi Hai/Nahi
Sun Pharmaceutical Industries Limited
13.88% 1146.351 Cr
Divi's Laboratories Limited
9.57% 790.584 Cr
Lupin Limited
6.30% 520.545 Cr
Cipla Limited
6.01% 496.032 Cr
Apollo Hospitals Enterprise Limited
5.48% 452.664 Cr
Dr. Reddy's Laboratories Limited
5.25% 433.564 Cr
GlaxoSmithKline Pharmaceuticals Limited
3.63% 299.994 Cr
MedPlus Health Services Limited
3.54% 292.413 Cr
Vijaya Diagnostic Centre Limited
3.43% 283.298 Cr
Abbott India Limited
3.23% 266.516 Cr
Ajanta Pharma Limited
3.14% 259.602 Cr
Narayana Hrudayalaya Limited
3.04% 251.077 Cr
Gland Pharma Limited
2.59% 214.109 Cr
Aurobindo Pharma Limited
2.53% 209.270 Cr
Dr. Lal Path Labs Limited
2.38% 196.360 Cr
Zydus Lifesciences Limited
2.15% 177.706 Cr
Torrent Pharmaceuticals Limited
2.03% 167.218 Cr
Alkem Laboratories Limited
2.01% 165.594 Cr
JB Chemicals & Pharmaceuticals Limited
1.95% 161.183 Cr
Mankind Pharma Limited
1.94% 160.007 Cr
Thyrocare Technologies Limited
1.88% 155.058 Cr
Sanofi India Limited
1.66% 136.851 Cr
Pfizer Limited
1.65% 136.618 Cr
IPCA Laboratories Limited
1.33% 110.052 Cr
Sanofi Consumer Healthcare India Limited
1.28% 105.548 Cr
Sai Life Sciences Limited
1.21% 99.672 Cr
Suraksha Diagnostic Limited
1.15% 94.835 Cr
Fortis Healthcare Limited
0.92% 75.677 Cr
Biocon Limited
0.89% 73.506 Cr
Syngene International Limited
0.86% 71.318 Cr
AstraZeneca Pharma India Limited
0.67% 55.626 Cr
Indoco Remedies Limited
0.52% 42.675 Cr
Orchid Pharma Limited
0.48% 39.467 Cr
Emcure Pharmaceuticals Limited
0.37% 30.845 Cr
Krishna Institute Of Medical Sciences Limited
0.37% 30.332 Cr
Concord Biotech Limited
0.21% 16.969 Cr
Akums Drugs and Pharmaceuticals Limited
0.20% 16.361 Cr

Insight on the composition of the Nippon India Pharma Fund - Growth Plan - Growth Option